Compare IMMX & AGBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IMMX | AGBK |
|---|---|---|
| Founded | 2014 | 1999 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 784.8M | 823.2M |
| IPO Year | 2021 | 2025 |
| Metric | IMMX | AGBK |
|---|---|---|
| Price | $7.92 | $6.33 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 11 |
| Target Price | ★ $24.05 | $10.47 |
| AVG Volume (30 Days) | ★ 1.2M | 563.9K |
| Earning Date | 11-12-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $58.64 |
| Revenue Next Year | N/A | $35.59 |
| P/E Ratio | ★ N/A | $46.19 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.78 | $4.43 |
| 52 Week High | $15.10 | $12.21 |
| Indicator | IMMX | AGBK |
|---|---|---|
| Relative Strength Index (RSI) | 42.67 | 57.80 |
| Support Level | $7.82 | $5.91 |
| Resistance Level | $9.04 | $7.59 |
| Average True Range (ATR) | 0.62 | 0.40 |
| MACD | 0.16 | 0.12 |
| Stochastic Oscillator | 41.81 | 93.71 |
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
AGI Inc is a technology-powered provider of specialized financial services in Brazil. It empowers clients to access their social security benefits, severance fund benefits, and public or private sector payrolls through secured lending solutions and complementary banking, credit and insurance products tailored as per client needs. The company has one operating segment related to the banking business. The Bank provides a standardized set of financial products and services exclusively to individuals, mainly focused on credit, including digital accounts, cards, payroll and personal loans, and insurance offered through partners.